US Stock MarketDetailed Quotes
BTCY Biotricity
- 1.3700
- +0.0300+2.24%
Trading May 1 11:13 ET
12.97MMarket Cap-783P/E (TTM)
1.3900High1.3300Low23.27KVolume1.3300Open1.3400Pre Close31.72KTurnover0.29%Turnover RatioLossP/E (Static)9.47MShares4.369852wk High-0.47P/B10.86MFloat Cap0.700752wk Low--Dividend TTM7.92MShs Float31.8000Historical High--Div YieldTTM4.48%Amplitude0.7000Historical Low1.3630Avg Price1Lot Size
Biotricity Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.92%-1.31M | 46.30%-2.39M | 54.64%-1.83M | 10.65%-13.55M | 60.50%-1.88M | 29.15%-3.18M | -37.40%-4.45M | -50.65%-4.04M | -36.84%-15.16M | -32.84%-4.76M |
| Net income from continuing operations | 37.83%-2.81M | 21.35%-3.69M | 28.54%-3.41M | 35.95%-18.66M | 16.74%-4.67M | 36.46%-4.52M | 56.36%-4.69M | 15.56%-4.78M | -88.05%-29.13M | -2.56%-5.61M |
| Operating gains losses | 151.84%339.82K | -65.07%64.81K | -136.81%-101.45K | -29.21%483.87K | 75.70%-112.26K | -89.15%134.94K | 133.77%185.56K | -38.87%275.64K | 142.49%683.56K | 53.77%-461.92K |
| Depreciation and amortization | 0.00%1.49K | 0.00%1.49K | 0.00%1.49K | 157.93%5.95K | -0.07%1.49K | 81.68%1.49K | --1.49K | --1.49K | --2.31K | --1.49K |
| Other non cash items | 67.09%546.41K | 264.76%686.94K | 513.62%645.02K | -86.67%1.66M | -33.41%1.04M | -77.40%327.01K | -97.36%188.33K | -95.50%105.12K | 113.18%12.49M | -51.88%1.57M |
| Change In working capital | -45.23%444.27K | 260.04%377.78K | 437.79%830.98K | 2,063.52%2.31M | 314.22%1.58M | 575.50%811.09K | -130.05%-236.06K | 3,264.90%154.52K | 81.27%-117.58K | -9.46%-737.2K |
| -Change in receivables | 161.82%33.86K | 65.55%-80.43K | -284.14%-331.01K | 257.57%686.2K | 4,981.79%727K | 103.77%12.93K | -172.08%-233.49K | 144.74%179.76K | 58.00%-435.48K | 83.95%-14.89K |
| -Change in inventory | 201.21%79.29K | 120.68%87.36K | 120.65%121.45K | -161.92%-1.49M | 16.14%-405.11K | 67.59%-78.34K | -784.68%-422.5K | -734.49%-588.13K | -205.41%-570.43K | -171.94%-483.09K |
| -Change in prepaid assets | 134.80%15.32K | 1,716.38%380.72K | -649.84%-32.33K | -270.59%-224.82K | -231.51%-152.94K | -241.81%-44.01K | 69.75%-23.55K | 95.00%-4.31K | 61.26%-60.67K | 157.95%116.29K |
| -Change in payables and accrued expense | -65.69%315.81K | -102.23%-9.87K | 89.15%1.07M | 252.11%3.34M | 496.69%1.41M | 115.70%920.51K | -7.18%443.48K | 41.82%567.2K | 26.14%949K | -75.66%-355.51K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.92%-1.31M | 46.30%-2.39M | 54.64%-1.83M | 10.65%-13.55M | 60.50%-1.88M | 29.15%-3.18M | -37.40%-4.45M | -50.65%-4.04M | -36.84%-15.16M | -32.84%-4.76M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -29.77K | -1 | |||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---29.77K | ---1 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---29.77K | ---1 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -82.48%194.55K | 1,357.25%3.43M | 259.52%1.33M | -92.05%2M | 1,187.20%2M | -88.46%1.11M | -101.84%-272.78K | -243.39%-833.22K | 106.24%25.17M | -94.00%155.18K |
| Net issuance payments of debt | -89.03%200.6K | --1.42M | --1.34M | -63.84%3.83M | --2M | -82.09%1.83M | --0 | --0 | -15.49%10.6M | --0 |
| Net common stock issuance | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --14.8M | --0 |
| Net preferred stock issuance | --0 | 2,820.04%1.9M | --0 | -588.89%-895.56K | --0 | -116.00%-496.8K | -169.85%-69.85K | ---328.9K | -165.00%-130K | --0 |
| Cash dividends paid | 97.26%-6.05K | 97.08%-5.92K | 98.83%-6.05K | 2.00%-946.78K | 96.95%-6.05K | 44.35%-220.99K | -22.21%-202.93K | -152.30%-516.82K | -60.23%-966.11K | -518.27%-198.15K |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -98.57%12.5K | --0 | --0 | --0 | -91.45%12.5K | 1,183.90%872.29K | --353.33K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.48%194.55K | 1,357.25%3.43M | 259.52%1.33M | -92.05%2M | 1,187.20%2M | -88.46%1.11M | -101.84%-272.78K | -243.39%-833.22K | 106.24%25.17M | -94.00%155.18K |
| Net cash flow | ||||||||||
| Beginning cash position | -51.97%1.2M | -99.29%51.43K | -95.27%570.46K | 448.11%12.07M | -97.31%451.42K | -78.64%2.5M | 3,475.60%7.21M | 448.11%12.07M | 131.78%2.2M | 405.10%16.79M |
| Current changes in cash | 46.29%-1.11M | 122.01%1.04M | 89.68%-502.97K | -215.75%-11.55M | 102.59%119.22K | -140.57%-2.07M | -140.81%-4.72M | -132.00%-4.87M | 788.53%9.98M | -363.05%-4.6M |
| Effect of exchange rate changes | -113.99%-3.21K | 711.26%108.84K | -217.53%-16.05K | 145.45%49.86K | 99.86%-177 | 530.68%22.96K | 116.52%13.42K | -86.39%13.66K | -185.01%-109.71K | 4.45%-123.5K |
| End cash Position | -81.15%85.09K | -51.97%1.2M | -99.29%51.43K | -95.27%570.46K | -95.27%570.46K | -97.31%451.42K | -78.64%2.5M | 3,475.60%7.21M | 448.11%12.07M | 448.11%12.07M |
| Free cash flow | 58.92%-1.31M | 46.30%-2.39M | 54.64%-1.83M | 10.83%-13.55M | 60.50%-1.88M | 29.62%-3.18M | -37.40%-4.45M | -50.65%-4.04M | -37.11%-15.19M | -32.84%-4.76M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg